Clinical Trial Update: Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of peginterferon beta-1a in relapsing multiple sclerosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Plegridy (Peginterferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2014-09-19